Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells

M. Page Haynes, Diviya Sinha, Kerry Strong Russell, Mark Collinge, David Fulton, Manuel Morales-Ruiz, William C. Sessa, Jeffrey R. Bender

Research output: Contribution to journalArticle

447 Citations (Scopus)

Abstract

17β-Estradiol (E2) is a rapid activator of endothelial nitric oxide synthase (eNOS). The product of this activation event, NO, is a fundamental determinant of cardiovascular homeostasis. We previously demonstrated that E2-stimulated endothelial NO release can occur without an increase in cytosolic Ca2+. Here we demonstrate for the first time, to our knowledge, that E2 rapidly induces phosphorylation and activation of eNOS through the phosphatidylinositol 3 (PI3)-kinase-Akt pathway. E2 treatment (10 ng/mL) of the human endothelial cell line, EA.hy926, resulted in increased NO production, which was abrogated by the PI3-kinase inhibitor, LY294002, and the estrogen receptor antagonist ICI 182,780. E2 stimulated rapid Akt phosphorylation on serine 473. As has been shown for vascular endothelial growth factor, eNOS is an E2-activated Akt substrate, demonstrated by rapid eNOS phosphorylation on serine 1177, a critical residue for eNOS activation and enhanced sensitivity to resting cellular Ca2+ levels. Adenoviral-mediated EA.hy926 transduction confirmed functional involvement of Akt, because a kinase-deficient, dominant-negative Akt abolished E2-stimulated NO release. The membrane-impermeant E2BSA conjugate, shown to bind endothelial cell membrane sites, also induced rapid Akt and consequent eNOS phosphorylation. Thus, engagement of membrane estrogen receptors results in rapid endothelial NO release through a PI3-kinase-Akt-dependent pathway. This explains, in part, the reduced requirement for cytosolic Ca2+ fluxes and describes an important pathway relevant to cardiovascular pathophysiology.

Original languageEnglish (US)
Pages (from-to)677-682
Number of pages6
JournalCirculation research
Volume87
Issue number8
DOIs
StatePublished - Oct 13 2000

Fingerprint

Phosphatidylinositol 3-Kinase
Nitric Oxide Synthase Type III
Estrogen Receptors
Endothelial Cells
Membranes
Phosphorylation
Serine
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
Vascular Endothelial Growth Factor A
Estradiol
Homeostasis
Phosphotransferases
Cell Membrane
Cell Line

Keywords

  • Akt
  • Endothelial nitric oxide synthase
  • Estrogen
  • Membrane receptor

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells. / Haynes, M. Page; Sinha, Diviya; Russell, Kerry Strong; Collinge, Mark; Fulton, David; Morales-Ruiz, Manuel; Sessa, William C.; Bender, Jeffrey R.

In: Circulation research, Vol. 87, No. 8, 13.10.2000, p. 677-682.

Research output: Contribution to journalArticle

Haynes, M. Page ; Sinha, Diviya ; Russell, Kerry Strong ; Collinge, Mark ; Fulton, David ; Morales-Ruiz, Manuel ; Sessa, William C. ; Bender, Jeffrey R. / Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells. In: Circulation research. 2000 ; Vol. 87, No. 8. pp. 677-682.
@article{279ba3dfe9954529886c519b690f5bb3,
title = "Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells",
abstract = "17β-Estradiol (E2) is a rapid activator of endothelial nitric oxide synthase (eNOS). The product of this activation event, NO, is a fundamental determinant of cardiovascular homeostasis. We previously demonstrated that E2-stimulated endothelial NO release can occur without an increase in cytosolic Ca2+. Here we demonstrate for the first time, to our knowledge, that E2 rapidly induces phosphorylation and activation of eNOS through the phosphatidylinositol 3 (PI3)-kinase-Akt pathway. E2 treatment (10 ng/mL) of the human endothelial cell line, EA.hy926, resulted in increased NO production, which was abrogated by the PI3-kinase inhibitor, LY294002, and the estrogen receptor antagonist ICI 182,780. E2 stimulated rapid Akt phosphorylation on serine 473. As has been shown for vascular endothelial growth factor, eNOS is an E2-activated Akt substrate, demonstrated by rapid eNOS phosphorylation on serine 1177, a critical residue for eNOS activation and enhanced sensitivity to resting cellular Ca2+ levels. Adenoviral-mediated EA.hy926 transduction confirmed functional involvement of Akt, because a kinase-deficient, dominant-negative Akt abolished E2-stimulated NO release. The membrane-impermeant E2BSA conjugate, shown to bind endothelial cell membrane sites, also induced rapid Akt and consequent eNOS phosphorylation. Thus, engagement of membrane estrogen receptors results in rapid endothelial NO release through a PI3-kinase-Akt-dependent pathway. This explains, in part, the reduced requirement for cytosolic Ca2+ fluxes and describes an important pathway relevant to cardiovascular pathophysiology.",
keywords = "Akt, Endothelial nitric oxide synthase, Estrogen, Membrane receptor",
author = "Haynes, {M. Page} and Diviya Sinha and Russell, {Kerry Strong} and Mark Collinge and David Fulton and Manuel Morales-Ruiz and Sessa, {William C.} and Bender, {Jeffrey R.}",
year = "2000",
month = "10",
day = "13",
doi = "10.1161/01.RES.87.8.677",
language = "English (US)",
volume = "87",
pages = "677--682",
journal = "Circulation Research",
issn = "0009-7330",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells

AU - Haynes, M. Page

AU - Sinha, Diviya

AU - Russell, Kerry Strong

AU - Collinge, Mark

AU - Fulton, David

AU - Morales-Ruiz, Manuel

AU - Sessa, William C.

AU - Bender, Jeffrey R.

PY - 2000/10/13

Y1 - 2000/10/13

N2 - 17β-Estradiol (E2) is a rapid activator of endothelial nitric oxide synthase (eNOS). The product of this activation event, NO, is a fundamental determinant of cardiovascular homeostasis. We previously demonstrated that E2-stimulated endothelial NO release can occur without an increase in cytosolic Ca2+. Here we demonstrate for the first time, to our knowledge, that E2 rapidly induces phosphorylation and activation of eNOS through the phosphatidylinositol 3 (PI3)-kinase-Akt pathway. E2 treatment (10 ng/mL) of the human endothelial cell line, EA.hy926, resulted in increased NO production, which was abrogated by the PI3-kinase inhibitor, LY294002, and the estrogen receptor antagonist ICI 182,780. E2 stimulated rapid Akt phosphorylation on serine 473. As has been shown for vascular endothelial growth factor, eNOS is an E2-activated Akt substrate, demonstrated by rapid eNOS phosphorylation on serine 1177, a critical residue for eNOS activation and enhanced sensitivity to resting cellular Ca2+ levels. Adenoviral-mediated EA.hy926 transduction confirmed functional involvement of Akt, because a kinase-deficient, dominant-negative Akt abolished E2-stimulated NO release. The membrane-impermeant E2BSA conjugate, shown to bind endothelial cell membrane sites, also induced rapid Akt and consequent eNOS phosphorylation. Thus, engagement of membrane estrogen receptors results in rapid endothelial NO release through a PI3-kinase-Akt-dependent pathway. This explains, in part, the reduced requirement for cytosolic Ca2+ fluxes and describes an important pathway relevant to cardiovascular pathophysiology.

AB - 17β-Estradiol (E2) is a rapid activator of endothelial nitric oxide synthase (eNOS). The product of this activation event, NO, is a fundamental determinant of cardiovascular homeostasis. We previously demonstrated that E2-stimulated endothelial NO release can occur without an increase in cytosolic Ca2+. Here we demonstrate for the first time, to our knowledge, that E2 rapidly induces phosphorylation and activation of eNOS through the phosphatidylinositol 3 (PI3)-kinase-Akt pathway. E2 treatment (10 ng/mL) of the human endothelial cell line, EA.hy926, resulted in increased NO production, which was abrogated by the PI3-kinase inhibitor, LY294002, and the estrogen receptor antagonist ICI 182,780. E2 stimulated rapid Akt phosphorylation on serine 473. As has been shown for vascular endothelial growth factor, eNOS is an E2-activated Akt substrate, demonstrated by rapid eNOS phosphorylation on serine 1177, a critical residue for eNOS activation and enhanced sensitivity to resting cellular Ca2+ levels. Adenoviral-mediated EA.hy926 transduction confirmed functional involvement of Akt, because a kinase-deficient, dominant-negative Akt abolished E2-stimulated NO release. The membrane-impermeant E2BSA conjugate, shown to bind endothelial cell membrane sites, also induced rapid Akt and consequent eNOS phosphorylation. Thus, engagement of membrane estrogen receptors results in rapid endothelial NO release through a PI3-kinase-Akt-dependent pathway. This explains, in part, the reduced requirement for cytosolic Ca2+ fluxes and describes an important pathway relevant to cardiovascular pathophysiology.

KW - Akt

KW - Endothelial nitric oxide synthase

KW - Estrogen

KW - Membrane receptor

UR - http://www.scopus.com/inward/record.url?scp=0034644608&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034644608&partnerID=8YFLogxK

U2 - 10.1161/01.RES.87.8.677

DO - 10.1161/01.RES.87.8.677

M3 - Article

C2 - 11029403

AN - SCOPUS:0034644608

VL - 87

SP - 677

EP - 682

JO - Circulation Research

JF - Circulation Research

SN - 0009-7330

IS - 8

ER -